MedTrace Logo

Saw Palmetto: Symptom Management for Men During Radiation Therapy

NCT01585246 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2019-09-30

Study results available
· View outcomes & findings →

Summary

The aim of this study is to test whether Saw Palmetto, is useful in preventing or reducing the side effects for men undergoing radiation therapy for prostate cancer. Urinary symptoms will be recorded each week, as well as assessment of quality of life through: 1) Physical Well-Being 2) Social/Family Well-being 3) Emotional Well-Being, and 4) Functional Well-Being.

Conditions

Interventions

DRUG

Saw Palmetto

1 of 3 doses of Saw Palmetto (320, 640, 960mg/day)

DRUG

soybean oil soft gel

placebo (soybean oil soft gel)

Sponsors & Collaborators

Principal Investigators

  • Gwen Wyatt, PhD, RN · MichiganState University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01585246 on ClinicalTrials.gov